FALLOPIAN TUBE CANCER
Clinical trials for FALLOPIAN TUBE CANCER explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CANCER trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough ovarian cancer? trial tests targeted drug vs standard chemo
Disease control TerminatedThis study tested a new drug called luveltamab tazevibulin against standard chemotherapy in about 600 women whose ovarian cancer had stopped responding to platinum-based treatment. The drug targets a protein (FOLR1) found on many ovarian cancer cells. The trial was terminated ear…
Matched conditions: FALLOPIAN TUBE CANCER
Phase: PHASE2, PHASE3 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Immune cell therapy shows promise for hard-to-treat ovarian cancers
Disease control TerminatedThis early-phase study tested a new treatment for women with ovarian, fallopian tube, or peritoneal cancer that returned or didn't respond to standard therapy. The approach involved taking a type of white blood cell (monocytes) from each participant, activating them with immune-b…
Matched conditions: FALLOPIAN TUBE CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Ovarian cancer drug combo trial halted early
Disease control TerminatedThis early-phase study tested a new drug (STRO-002) combined with bevacizumab in people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal was to check safety and find the right dose. The study was stopped early, so results are limited.
Matched conditions: FALLOPIAN TUBE CANCER
Phase: PHASE1 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Scientists tap cancer fluids for clues
Knowledge-focused TerminatedThis study collected fluid from the abdomen or lungs, plus blood, from 22 adults with solid tumors. The goal was to learn more about how cancer works, not to test a new treatment. Researchers hope this knowledge will lead to better therapies in the future.
Matched conditions: FALLOPIAN TUBE CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:21 UTC